Global Biologics Outsourcing Market: Insights, Trends & Forecast (2019-2023)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,700	105 Pages	Koncept Analytics	October, 2019	KOAN16064938

Best Price Guarantee
Price	from $1,700
Length	105 Pages
Publisher	Koncept Analytics
Published Date	October, 2019
SKU	KOAN16064938

Global Biologics Outsourcing Market: Insights, Trends & Forecast (2019-2023)

The global biologics outsourcing market is estimated to reach US$26.4 billion in 2023, growing at a CAGR of 16.77% for the period spanning from 2019 to 2023. The factors such as increasing aging population, higher healthcare spending, rising incidences of chronic conditions, increasing R&D spending on biologics drugs and growing focus on biologics are expected to drive the market. However, growth of the industry will be challenged by high capital requirement, high technical requirement, regulatory issues and ability to capture customers from established competitors. A few notable trends include new drug development and increasing demand for antibody conjugates.

The global biologics outsourcing market is broadly segmented into two types which are instruments and kits & reagents. The use of antibodies for treating various chronic diseases such as asthma and diabetes is increasing investment in research activities which has stimulated the demand for biologics outsourcing market globally.

The fastest growing regional market is China owing to the Chinese government which has issued many regulations and policies to support the development of the biologics outsourcing market in China. Marketing Authorization Holder or MAH, Pilot Program for drug approval process allows biologics applicants with products that are manufactured in China to outsource the manufacturing process to third party biologics outsourcing service providers. The U.S. and Asia are highly established premium markets that contribute to significant shares in the global market.

Scope of the report:

The report provides a comprehensive analysis of the global biologics outsourcing market, segmented into two types which are instruments and kits & reagents.
The major regional markets have been analyzed, with the coverage of China.
The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
The competitive landscape of the market, along with the company profiles of leading players (Lonza Group, Wuxi Biologics, Boehringer Inhgelheim, Catalent Inc., Abzena and Thermo Fisher) are also presented in detail.

Key Target Audience:

Pharmaceutical Biotech Manufacturers
Individual Researchers
CROs/CDMOs/CMOs
Academic Institutes
Investment Banks
Government Bodies & Regulating Authorities

1. Market Overview: 1.1 Pharmaceutical Industry; Table 1: Segmentation of Pharmaceutical Industry; 1.2 Biologics; Table 2: Biologics Value Chain; 1.3 Manufacturing Process of Biologics; Table 3: Manufacturing Process of Biologics; 1.4 Medical Uses for Biologics; 1.5 Products of Biologics; Table 4: Products/Segments of Biologics; 1.6 Biologics Outsourcing
2. Global Pharmaceutical Market: 2.1 Global Pharmaceutical Market by Value; Table 5: Global Pharmaceutical Market by Value (2014-2018); 2.2 Global Pharmaceutical Market Forecast by Value; Table 6: Global Pharmaceutical Market Forecast by Value (2019-2023); 2.3 Global Pharmaceutical Market by Segment; Table 7: Global Pharmaceutical Market by Segment (2018); 2.3.1 Global Small Molecule Market by Value; Table 8: Global Small Molecule Market by Value (2014-2018); 2.3.2 Global Small Molecule Forecast Market by Value; Table 9: Global Small Molecule Forecast Market by Value (2019-2023); 2.3.3 Global Generics Market by Value; Table 10: Global Generics Market by Value (2014-2018); 2.3.4 Global Generics Market Forecast by Value; Table 11: Global Generics Market Forecast by Value (2019-2023); 2.3.5 Global OTC Market by Value; Table 12: Global OTC Market by Value (2014-2018); 2.3.6 Global OTC Market Forecast by Value; Table 13: Global OTC Market Forecast by Value (2019-2023); 2.3.7 Global Biosimilar Market by Value; Table 14: Global Biosimilar Market by Value (2014-2018); 2.3.8 Global Biosimilar Market Forecast by Value; Table 15: Global Biosimilar Market Forecast by Value (2019-2023)
3. Global Biologics Market: 3.1 Global Biologics Market by Value; Table 16: Global Biologics Market by Value (2014-2018); 3.2 Global Biologics Market Forecast by Value; Table 17: Global Biologics Market Forecast by Value (2019-2023); 3.3 Global Biologics Market by Segment; Table 18: Global Biologics Market by Segment (2018); 3.3.1 Global mAb Market by Value; Table 19: Global mAb Market by Value (2014-2018); 3.3.2 Global mAb Market Forecast by Value; Table 20: Global mAb Market Forecast by Value (2019-2023); 3.4 Global Biologics Market by Region; Table 21: Global Biologics Market by Region (2018); 3.5 Global Biologics Market Growth by Region; Table 22: Global Biologics Market Growth by Region (2018-2023)
4. Global Biologics Outsourcing Market: 4.1 Global Biologics Outsourcing Market by Value; Table 23: Global Biologics Outsourcing Market by Value (2014-2018); 4.2 Global Biologics Outsourcing Market Forecast by Value; Table 24: Global Biologics Outsourcing Market Forecast by Value (2019-2023); 4.3 Global Biologics Outsourcing Market by Type; Table 25: Global Biologics Outsourcing Market by Type (2018); 4.3.1 Global Biologics Outsourcing Instrument Market by Value; Table 26: Global Biologics Outsourcing Instrument Market by Value (2018-2023); 4.3.2 Global Biologics Outsourcing Kits & Reagents Market Forecast by Value; Table 27: Global Biologics Outsourcing Kits & Reagents Market Forecast by Value (2018-2023); 4.4 Global Biologics Outsourcing Market Growth by Region; Table 28: Global Biologics Outsourcing Market Growth by Region (2018-2023)
5. China Biologics/Biologics Outsourcing Market: 5.1 China Biologics Market by Value; Table 29: China Biologics Market by Value (2014-2018); 5.2 China Biologics Market Forecast by Value; Table 30: China Biologics Market Forecast by Value (2019-2023); 5.3 China Biologics Market by Segment; 5.3.1 China mAb Market by Value; Table 31: China mAb Market by Value (2014-2018); 5.3.2 China mAb Market Forecast by Value; Table 32: China mAb Market Forecast by Value (2019-2023); 5.4 China Biologics Outsourcing Market by Value; Table 33: China Biologics Outsourcing Market by Value (2014-2018); 5.5 China Biologics Outsourcing Market Forecast by Value; Table 34: China Biologics Outsourcing Market Forecast by Value (2019-2023)
6. Market Dynamics: 6.1 Growth Drivers; 6.1.1 Rising Ageing Population; Table 35: Global Population Above 65 Years (2014-2018); 6.1.2 Rising Incidences of Chronic Conditions; Table 36: The U.S. Prevalence of Chronic Diseases (2010-2030); 6.1.3 Escalating Healthcare Spending; Table 37: Global Healthcare Spending Per Capita (2014-2018); 6.1.4 Accelerating Economy; Table 38: Global GDP Per Capita (2014-2018); 6.1.5 Growing Focus on Biologics; 6.2 Key Trends & Developments; 6.2.1 Increasing Spending on Biologics Drugs; Table 39: Global Spending on Biologics Drugs (2014-2018); 6.2.2 New Drug Development; Table 40: Drug Discovery Market (2016/2025); 6.2.3 Increasing Demand for Antibody Conjugates; 6.3 Challenges; 6.3.1 High Capital Requirement; 6.3.2 High Technical Requirement; 6.3.3 Stringent Regulations; 6.3.4 Ability to Capture Customers from Established Competitors
7. Competitive Landscape: 7.1 Global Market; 7.1.1 Revenue and Market Cap Comparison; Table 41: Key Players - Revenue & Market Cap Comparison (2018); 7.1.2 Wuxi Biologics’ Share in Global Biologics Outsourcing Market; Table 42: Wuxi Biologics’ Share in Global Biologics Outsourcing Market (2018-2023); 7.1.3 Global Biologics Outsourcing Market Share by Company; Table 43: Global Biologics Outsourcing Market Share by Company (2018); 7.2 China; 7.2.1 China Biologics Outsourcing Market Share by Company; Table 44: China Biologics Outsourcing Market Share by Company (2018)
8. Company Profiles: 8.1 Lonza Group AG; 8.1.1 Business Overview; 8.1.2 Financial Overview; Table 45: Lonza Group Sales by Segments (2018); Table 46: Lonza Group Sales by Geographic Regions (2018); Table 47: Lonza Group Sales and Profit (2014-2018); 8.1.3 Business Strategies; 8.2 Wuxi Biologics; 8.2.1 Business Overview; 8.2.2 Financial Overview; Table 48: Wuxi Biologics Revenue by Region (2018); Table 49: Wuxi Biologics Revenue and Net Profit (2014-2018); 8.2.3 Business Strategies; 8.3 Boehringer Ingelheim; 8.3.1 Business Overview; 8.3.2 Financial Overview; Table 50: Boehringer Ingelheim Sales by Product Category (2018); Table 51: Boehringer Ingelheim Sales by Region (2018); Table 52: Boehringer Ingelheim Net Sales and Net Income (2014-2018); 8.3.3 Business Strategies; 8.4 Catalent Inc.; 8.4.1 Business Overview; 8.4.2 Financial Overview; Table 53: Catalent Inc. Segments and Their Offerings & Services (2018); Table 54: Catalent Inc. Revenue by Segment (2018); Table 55: Catalent Inc. Revenue by Region (2018); Table 56: Catalent Inc. Net Revenue and Net Earnings (2014-2018); 8.4.3 Business Strategies; 8.5 Abzena Limited; 8.5.1 Business Overview; 8.5.2 Financial Overview; Table 57: Abzena Revenue by Segment (2018); Table 58: Abzena Revenue by Region (2018); Table 59: Abzena Revenue and Loss (2015-2018); 8.5.3 Business Strategies; 8.6 Thermo Fisher; 8.6.1 Business Overview; 8.6.2 Financial Overview; Table 60: Thermo Fisher Revenue by Segment (2018); Table 61: Thermo Fisher Revenue by Region (2018); Table 62: Thermo Fisher Revenue and Net Income (2014-2018); 8.6.3 Business Strategies